MYGN Myriad Genetics Inc IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Best Diagnostics Stocks 2026 →

Myriad Genetics (MYGN) Stock: Buy, Sell, or Hold?

$5.68
-0.04 (-0.70%) â–ŧ
5d: -9.7% 30d: +36.87% 90d: +87.46%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (48%)
Quality Score
38/100
Position
FAIR
30-Day Fair Range
$4.43 – $6.21
Position: FAIR
Forward P/E & Valuation
-8.7x CHEAP
vs 50.8x historical avg
Wall Street Target
$5.22
-8.1% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$5.47 / $6.75
Trend: Sideways
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: MYGN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When MYGN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: MYGN is currently trading at $5.68, which is considered fair relative to its 30-day fair value range of $4.43 to $6.21. From a valuation perspective, the stock is trading at a discount (Forward PE: -8.7) compared to its historical average (50.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, MYGN is showing sideways momentum. Immediate support is located at $5.47, while resistance sits at $6.75.

Market Sentiment: MYGN scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.43 - $6.21
Company Quality Score 38/100 (SELL)
Volume Confirmation HIGH
Confidence Score 47.6%

Trading Range & Key Levels

30-Day Trading Range $4.43 - $6.21
Current vs Trading Range FAIR
Support Level $5.47
Resistance Level $6.75
Current Trend Sideways
Technical data as of Nov 12, 2026

Protect Your Profits

Holding MYGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BEARISH: Weak technical setup (13/100)
  • BULLISH: High volume confirmation
  • BEARISH: Trading above Wall St target ($5.22)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -8.72
Wall Street Target $5.22 (-8.1%)
Revenue Growth (YoY) -1.5%
Profit Margin -16.1%
PE vs Historical -8.7 vs 50.8 CHEAP
Share MYGN Analysis

Share this live MYGN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (MYGN)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits saw a single bullish message about $MYGN, with the user expressing a bullish sentiment toward the stock, referring to it as a diamond. No recent news articles were available for analysis.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 2:48 AM ET
Data refreshes hourly during market hours. Next update: 3:48 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for MYGN.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
GH
Guardant Health Inc
STRONG BUY
26 analysts
$201 56 HOLD
NTRA
Natera Inc
STRONG BUY
23 analysts
$416 67 BUY
EXAS
EXACT Sciences Corporatiâ€Ļ
STRONG BUY
26 analysts
$106 52 HOLD
TMO
Thermo Fisher Scientificâ€Ļ
STRONG BUY
27 analysts
$752 48 HOLD
DHR
Danaher Corporation
STRONG BUY
24 analysts
$260 50 HOLD

Advanced MYGN Option Strategies

Professional options setups generated by AI based on today's MYGN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive MYGN Research Pages
MYGN Technical Chart MYGN Price Prediction MYGN Intrinsic Value DCF MYGN Earnings Date MYGN Investment Advisor MYGN Fair Price Analyzer MYGN Options Chain MYGN Options Advisor MYGN Options Analysis MYGN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals